{"log_id": 2983285207068713787, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 2.6e-05, "average": 0.997751, "min": 0.976588}, "location": {"width": 854, "top": 146, "height": 80, "left": 163}, "words": "5402名依那西普治疗患者出现机会致病菌感染的总体发生率为0.09%调整后暴露率"}, {"probability": {"variance": 0, "average": 0.999984, "min": 0.999984}, "location": {"width": 34, "top": 142, "height": 32, "left": 1146}, "words": "药"}, {"probability": {"variance": 3.3e-05, "average": 0.957139, "min": 0.951373}, "location": {"width": 60, "top": 186, "height": 29, "left": 1133}, "words": "批准"}, {"probability": {"variance": 0.000201, "average": 0.995807, "min": 0.917574}, "location": {"width": 854, "top": 195, "height": 79, "left": 164}, "words": "是每100个患者年中发生0.06个事件。上市后,全球范围内出现机会致病菌感染的病例"}, {"probability": {"variance": 0, "average": 0.805905, "min": 0.805905}, "location": {"width": 66, "top": 225, "height": 34, "left": 1132}, "words": "件"}, {"probability": {"variance": 3.5e-05, "average": 0.998278, "min": 0.965805}, "location": {"width": 854, "top": 245, "height": 78, "left": 165}, "words": "中约有一半为侵袭性真菌感染。最常报告的侵袭性真菌感染为肺囊虫属和曲霉菌属。侵"}, {"probability": {"variance": 1.6e-05, "average": 0.998566, "min": 0.980865}, "location": {"width": 855, "top": 294, "height": 79, "left": 167}, "words": "袭性真菌感染导致了一半以上机会致病菌感染患者的死亡。主要的致命性结果出现在肺"}, {"probability": {"variance": 2.8e-05, "average": 0.997416, "min": 0.971063}, "location": {"width": 842, "top": 344, "height": 80, "left": 167}, "words": "孢子虫性肺炎、未确定的系统性真菌感染以及曲霉菌病的患者中(参见“注意事项”)"}, {"probability": {"variance": 9e-06, "average": 0.996949, "min": 0.993517}, "location": {"width": 93, "top": 440, "height": 29, "left": 172}, "words": "自身抗体"}, {"probability": {"variance": 9e-06, "average": 0.998637, "min": 0.982475}, "location": {"width": 813, "top": 444, "height": 75, "left": 217}, "words": "在多个时间点对患者的血清样本进行自身抗体检测。依那西普治疗组类风湿关节炎"}, {"probability": {"variance": 0.000281, "average": 0.993425, "min": 0.904242}, "location": {"width": 859, "top": 494, "height": 76, "left": 172}, "words": "患者抗核抗体(ANA)(滴度≥1:40)的阳性比例(11%)大于安慰剂治疗组(5%)。通"}, {"probability": {"variance": 0.000124, "average": 0.995187, "min": 0.949749}, "location": {"width": 862, "top": 544, "height": 75, "left": 173}, "words": "过放射性免疫测定法(依那西普治疗组15%,安慰剂治疗组4%)和绿蝇短膜豆分析法"}, {"probability": {"variance": 2.4e-05, "average": 0.997946, "min": 0.976914}, "location": {"width": 850, "top": 593, "height": 75, "left": 186}, "words": "(依那西普治疗组3%,安慰剂治疗组0%)测得依那西普治疗患者抗双链DNA抗体阳"}, {"probability": {"variance": 2e-06, "average": 0.998853, "min": 0.992304}, "location": {"width": 862, "top": 642, "height": 74, "left": 177}, "words": "性的比例较高。依那西普治疗患者产生抗心磷脂抗体的增加比例与安慰剂组相似。长期"}, {"probability": {"variance": 2e-06, "average": 0.998738, "min": 0.995905}, "location": {"width": 457, "top": 712, "height": 55, "left": 179}, "words": "使用依那西普治疗对自身抗体产生的影响未知"}, {"probability": {"variance": 0.000353, "average": 0.994111, "min": 0.894145}, "location": {"width": 819, "top": 739, "height": 74, "left": 226}, "words": "罕见报告患者(包括类风湿因子阳性患者)产生其他自身抗体的同时出现狼疮样综"}, {"probability": {"variance": 0.004804, "average": 0.982051, "min": 0.624943}, "location": {"width": 863, "top": 788, "height": 76, "left": 182}, "words": "合征或皮疹,这些皮疹与亚急性皮肤红斑狼疮或盘状红斑狼疮的临床表现和活组织检查"}, {"probability": {"variance": 1e-06, "average": 0.999202, "min": 0.998477}, "location": {"width": 47, "top": 883, "height": 26, "left": 185}, "words": "相似"}, {"probability": {"variance": 0, "average": 0.999613, "min": 0.998506}, "location": {"width": 326, "top": 914, "height": 47, "left": 185}, "words": "全血细胞减少和再生障碍性贫血"}, {"probability": {"variance": 0.000192, "average": 0.996647, "min": 0.914433}, "location": {"width": 817, "top": 933, "height": 74, "left": 235}, "words": "上市后曾报告全血细胞减少症和再生障碍性贫血的病例,有些造成了死亡(参见“注"}, {"probability": {"variance": 2.5e-05, "average": 0.996068, "min": 0.98645}, "location": {"width": 95, "top": 1027, "height": 28, "left": 190}, "words": "意事项”)"}, {"probability": {"variance": 5e-06, "average": 0.998586, "min": 0.994187}, "location": {"width": 118, "top": 1074, "height": 29, "left": 191}, "words": "间质性肺病"}, {"probability": {"variance": 0.000124, "average": 0.980882, "min": 0.969757}, "location": {"width": 93, "top": 1059, "height": 38, "left": 749}, "words": "医药"}, {"probability": {"variance": 5.6e-05, "average": 0.996797, "min": 0.958606}, "location": {"width": 750, "top": 1082, "height": 70, "left": 240}, "words": "上市后曾报告间质性肺病的病例(包括肺炎和肺纤维化),有些造成了死亡。"}, {"probability": {"variance": 0, "average": 0.99984, "min": 0.999624}, "location": {"width": 117, "top": 1170, "height": 32, "left": 196}, "words": "实验室评价"}, {"probability": {"variance": 2e-06, "average": 0.998974, "min": 0.994107}, "location": {"width": 825, "top": 1174, "height": 76, "left": 240}, "words": "根据临床研究的结果,对患者除了仔细的医疗处置和监测外通常不需要进行特殊的"}, {"probability": {"variance": 0, "average": 0.999229, "min": 0.998111}, "location": {"width": 118, "top": 1265, "height": 34, "left": 197}, "words": "实验室评价"}, {"probability": {"variance": 0, "average": 0.999646, "min": 0.998845}, "location": {"width": 329, "top": 1303, "height": 46, "left": 199}, "words": "依那西普和阿那白滞素联合治疗"}, {"probability": {"variance": 2e-06, "average": 0.999123, "min": 0.995442}, "location": {"width": 825, "top": 1322, "height": 74, "left": 246}, "words": "在对同时接受依那西普和阿那白滞素治疗的患者进行研究时发现与单独使用依那"}, {"probability": {"variance": 1e-06, "average": 0.999271, "min": 0.994444}, "location": {"width": 869, "top": 1372, "height": 75, "left": 202}, "words": "西普相比,同时使用依那西普和阿那白滞素治疗时严重感染的发生率更高,并且有2%"}, {"probability": {"variance": 0.00328, "average": 0.979626, "min": 0.638087}, "location": {"width": 870, "top": 1420, "height": 77, "left": 205}, "words": "3139)的患者出现中性粒细胞减少(绝对中性粒细胞计数<1000m3)其中一名患者并"}, {"probability": {"variance": 8e-06, "average": 0.99826, "min": 0.986368}, "location": {"width": 764, "top": 1475, "height": 69, "left": 206}, "words": "发蜂窝组织炎,经住院治疗后康复(参见“注意事项”和“药物相互作用”)"}, {"probability": {"variance": 2e-06, "average": 0.998011, "min": 0.995398}, "location": {"width": 165, "top": 1619, "height": 39, "left": 831}, "words": "第8页共31页"}, {"probability": {"variance": 0.00253, "average": 0.970502, "min": 0.834936}, "location": {"width": 153, "top": 1658, "height": 28, "left": 212}, "words": "版本号:200901"}], "language": 3}